Chief Medical Officer (Part-time)

Role Overview

Start Date: ASAP
Location: Fully Remote, USA (consideration for European based candidates)
Contract Type: Freelance / Consultant – 0.4–0.6 FTE, Indefinite
Language: English
Project: Haemato-Oncology (AML)

Key Responsibilities

• Provide overall medical oversight and strategic direction for the company's clinical programme in AML.
• Support and oversee protocol development for the upcoming clinical trial, ensuring scientific rigour and regulatory alignment.
• Act as the primary medical point of contact for Principal Investigators, fostering strong relationships and facilitating site-level engagement.
• Oversee safety monitoring activities, including review of adverse events and safety data throughout the trial lifecycle.
• Collaborate closely with the CEO and cross-functional teams to drive clinical milestones forward in a hands-on capacity.
• Contribute to interactions with regulatory authorities and support the preparation of key clinical and regulatory documents.

Requirements

• Medical degree (MD or equivalent) board certification or equivalent training in haematology, oncology, or haemato-oncology not required but beneficial.
• Demonstrated clinical development experience within the biotech or pharmaceutical industry, ideally in early-phase settings.
• Direct experience with AML or haemato-oncology clinical trials is essential, including familiarity with current treatment landscapes and trial design.
• Track record of engaging with Principal Investigators and the broader clinical community in this therapeutic area.
• Comfortable operating in a lean, hands-on environment where flexibility and initiative are critical.
• Strong communication, leadership, and problem-solving skills with the ability to work independently in a remote setting.